| Financial Year |
March 31 2023 |
| Monetary Funds |
408,948,505.98 |
| Held-for-trading Financial Assets |
447,423,007.50 |
| Notes Receivable |
5,183,930.64 |
| Accounts Receivable |
358,291,806.73 |
| Advances to Suppliers |
2,698,388.48 |
| Other Receivables |
4,172,018.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
214,820,901.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,255,602.15 |
| Total Current Assets |
1,756,642,911.28 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
556,202,642.56 |
| Under-construction Projects |
15,614,501.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,041,265.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,312,076.45 |
| Deferred Income Tax Assets |
3,672,151.01 |
| Other Non-Current Assets |
20,097,251.66 |
| Sub-Total of Non-Current Assets |
640,939,887.75 |
| Total Assets |
2,397,582,799.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
24,326,482.89 |
| Accounts Payable |
251,988,638.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,291,338.97 |
| Taxes Payable |
4,407,077.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,391,797.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
77,612.02 |
| Sub-Total of Current Liabilities |
311,079,962.52 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,803,130.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
45,821,278.94 |
| Total Liabilities |
356,901,241.46 |
| Paid-In Capital(Or Share Stock) |
239,200,000.00 |
| Capital Surplus |
1,103,412,184.10 |
| Surplus Reserve |
102,684,152.14 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
593,476,047.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,040,681,557.57 |
| Owner's Equity（Stockholder's Equity） |
2,040,681,557.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,397,582,799.03 |
